Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Independent boards (EAB and SAB) up and constituted (opens in new window)

Report on the composition of these boards.

Policy for third party access and use of project results (opens in new window)

On month 1, it will be an agreement on the key principles regarding 3rd party access allowing to discuss contract with non-EORTC groups. The full policy will be available by month 6.

Leaflet in lay language (opens in new window)

Leaflet explaining the project in lay language.

Publications

Abstract 176P Multiplex-immunoflourescence spatial patterns to predict triple-negative breast cancer molecular subtypes in the IMMUcan study (opens in new window)

Author(s): A. Joaquin Garcia, J. Krawczyk, M. Rediti, K. Gogolewski, M. Możejko, S. Tissot, S. Rusakiewicz, L. Despland, M. Morfouace, R. Liechti, F. Marzetta, X. Wang, D. Vincent, J-C. Goeminne, J. Oliveira, H.S. Hong, M. Cesaroni, C. Sotiriou, E. Szczurek, L. Buisseret
Published in: Immuno-Oncology and Technology, 2023
Publisher: Elsevier
DOI: 10.1016/j.iotech.2023.100635

Abstract 179P Integrating multiplex immunofluorescence with gene expression data in the IMMUcan HER2-positive breast cancer cohort (opens in new window)

Author(s): M. Rediti, A. Joaquin Garcia, S. Tissot, S. Rusakiewicz, L. Despland, M. Morfouace, R. Liechti, F. Marzetta, J. Oliveira, J-C. Goeminne, A. Capela Marques, L. Greillier, X. Wang, D. Vincent, H.S. Hong, M. Cesaroni, C. Sotiriou, L. Buisseret
Published in: Immuno-Oncology and Technology, 2023
Publisher: Elsevier
DOI: 10.1016/j.iotech.2023.100638

Abstract 186P Post-anti-PD1 tumor characterization of HPV-negative R/M SCCHN: An EORTC IMMUcan sub-project (opens in new window)

Author(s): A. Van Der Elst, D. Herrero Saboya, L. Michon, M. Morfouace, R. Liechti, D. Schulz, P. Devanand, R. Galot, A. Essabar, V. Pancaldi, J. Merlevede, H.S. Hong, L. Martignetti, C
Published in: Immuno-Oncology and Technology, 2023
Publisher: Elsevier
DOI: 10.1016/j.iotech.2023.100645

Abstract 199P Scalable multiplexed image analysis across cancer types as part of the IMMUcan consortium (opens in new window)

Author(s): N. Eling, J. Dorier, S. Rusakiewicz, S. Tissot, P. Devanand, M. Daniel, S. Déglise, B. Palau Fernandez, J. Windhager, M. Możejko, K. Gogolewski, J. Krawczyk, A. Essabbar, V. Pancaldi, E. Szczurek, M. Morfouace, H.S. Hong, R. Liechti, B. Bodenmiller, D. Schulz
Published in: Immuno-Oncology and Technology, 2023
Publisher: Elsevier
DOI: 10.1016/j.iotech.2023.100675

Abstract 195P IMMUcan: Toward a better understanding of the tumor microenvironment to inform precision oncology approaches (opens in new window)

Author(s): M. Morfouace, L. Buisseret, B. Besse, J-P. Machiels, C. Sotiriou, M-S. Robert, D. Schaer, S. Rusakiewicz, D. Schulz, B. Fournier, H.S. Hong, R. Liechti
Published in: Immuno-Oncology and Technology, 2023
Publisher: Elsevier
DOI: 10.1016/j.iotech.2023.100654

Abstract 202P Discovery of immunological cellular neighborhoods from protein markers in spatial tumor data (opens in new window)

Author(s): M. Możejko, K. Gogolewski, D. Schulz, N. Eling, J. Krawczyk, A. Możwiłło, M. Daniel, E. Staub, M. Mourface, H.S. Hong, B. Bodenmiller, E. Szczurek
Published in: Immuno-Oncology and Technology, 2023
Publisher: Elsevier
DOI: 10.1016/j.iotech.2023.100678

Abstract 2266P IMMUcan consortium: Focus on the first results of the non-small cell lung cancer (NSCLC) cohort (opens in new window)

Author(s): M. Morfouace, D. Schulz, N. Eling, F. Marzetta, C. Loizides, S. Rusakiewicz, R. Liechti, H.S. Hong, M-S. Robert, P. Bironzo, T. Cufer, K. Oselin, N. Cloarec, J. Oliveira, B. Bodenmiller, B. Besse,
Published in: Annals of Oncology, 2023
Publisher: Elsevier
DOI: 10.1016/j.annonc.2023.09.1294

Abstract 4522: Pathologic complete response rate across triple negative breast cancer subtypes in the IMMUcan study (opens in new window)

Author(s): Andrea Joaquin Garcia; Mattia Rediti; Abdelkader Benyagoub; Stéphanie Tissot; Sylvie Rusakiewicz; Robin Liechti; Flavia Marzetta; Nicolas Penel; Julio Oliveira; Jean-Charles Goeminne; Pierre Fournel; Andreia Capela; Xiaoxiao Wang; Delphine Vincent; Françoise Rothe; Marie Morfouace; Henoch Hong; Donald Jackson; Christos Sotiriou; Laurence Buisseret
Published in: Immuno-Oncology and Technology, 2023
Publisher: Elsevier
DOI: 10.1158/1538-7445.am2023-4522

Abstract 2274P: Deep learning-based prediction of pathologic complete response to neoadjuvant therapy in breast cancer using H&E images and RNA-Seq in the IMMUcan study (opens in new window)

Author(s): C. Esposito, A. Joaquin Garcia, M. Rediti, N. Penel, J. Oliveira, J-C. Goeminne, P. Fournel, A. Capela Marques, M. Morfouace, L. Buisseret, H.S. Hong, C. Maussion
Published in: Annals of Oncology, 2023
Publisher: Elsevier
DOI: 10.1016/j.annonc.2023.09.1302

Abstract 1P Integrated data analysis within IMMUcan identifies prognostic features of early NSCLC (opens in new window)

Author(s): D. Schulz, M. Morfouace, N. Eling, M. Daniel, S. Déglise, B. Palau Fernandez, J. Windhager, S. Rusakiewicz, S. Tissot, T. Trefzer, J. Merlevede, F. Marzetta, R. Liechti, H.S. Hong, T. Cufer, P. Bironzo, A-M.C. Dingemans, B. Besse, B. Bodenmiller
Published in: Immuno-Oncology and Technology, 2023
Publisher: Elsevier
DOI: 10.1016/j.iotech.2023.100473

Yes, IMMUcan! Unraveling the human tumor microenvironment (opens in new window)

Author(s): Henoch Hong, Robin Liechti, Marie Morfouace
Published in: Immuno-Oncology Insights, Issue 2021; 2(5),, 2021, Page(s) 301–309, ISSN 2059-7800
Publisher: BioInsights Publishing Ltd
DOI: 10.18609/ioi.2021.038

CD4+ T cell activation distinguishes response to anti-PD-L1+anti-CTLA4 therapy from anti-PD-L1 monotherapy. (opens in new window)

Author(s): Franken A, Bila M, Mechels A, Kint S, Van Dessel J, Pomella V, Vanuytven S, Philips G, Bricard O, Xiong J, Boeckx B, Hatse S, Van Brussel T, Schepers R, Van Aerde C, Geurs S, Vandecaveye V, Hauben E, Vander Poorten V, Verbandt S, Vandereyken K, Qian J, Tejpar S, Voet T, Clement PM, Lambrechts D.
Published in: Immunity, 2024, ISSN 1097-4180
Publisher: Elsevier
DOI: 10.1016/j.immuni.2024.02.007

Meta-analysis of human cancer single cell RNA-seq datasets using the IMMUcan database. (opens in new window)

Author(s): Jordi Camps; Floriane Noël; Robin Liechti; Lucile Massenet-Regad; Sidwell Rigade; Lou Götz; Caroline Hoffmann; Elise Amblard; Melissa Saichi; Mahmoud M. Ibrahim; Jack Pollard; Jasna Medvedovic; Helge G. Roider; Vassili Soumelis
Published in: Cancer Research, 2023, ISSN 1538-7445
Publisher: AACR
DOI: 10.1158/0008-5472.can-22-0074

Searching for OpenAIRE data...

There was an error trying to search data from OpenAIRE

No results available

My booklet 0 0